top of page

RadioNano Therapeautics

A Light on

Cancer Treatment

Boron Neutron Capture Therapy and Nanotechnology
Toward the Revolutionized Cancer Therapy

研究概要

​Radio

Boron Neutron Capture Therapy

Boron Neutron Capture Therapy (BNCT) is a radiation therapy that uses the nuclear reaction between thermal neutrons and boron (Boron-10), to kill cancer cells with the alpha particles and lithium nuclei produced.
When a drug containing boron is administered to the body and irradiated with neutrons, cancer cells are destroyed by the energy released from the boron. The area of effect is localized, and cancer cells can be destroyed while minimizing damage to normal cells. Conventional radiotherapy requires multiple irradiations, but BNCT is expected to be highly effective even with a single irradiation.

radio-en-jpg2.jpg
nano-jpg-en2.jpg

​Nano

Nanotechnology

To further enhance the therapeutic effect of this BNCT, we have developed a new product called RN-501, a highly hydrophilic boron-containing inorganic nanoparticles.
The product is designed to deliver to cancer cells in a concentrated manner, which not only reduces side effects, but also makes it applicable to carcinomas that have been difficult to treat. In addition, the product's high accumulation and retention properties enable treatment at lower doses and for shorter periods of time than conventional formulations.

Nanotechnology to enhance the advantages of BNCT
A Next-Generation Radiotherapy
that could be the First Choice for Cancer Treatment.
top-wall_resize.jpg

Our Mission

Contribute to the health and future of cancer patients and their families through the development of novel biologically targeted radiation therapy

RadioNano Therapeutics Inc., a venture company, was established for the social implementation of Boron Neutron Capture Therapy (BNCT) using highly hydrophilic boron-containing inorganic nanoparticles developed by Professor Naoki Komatsu of the Graduate School of Human and Environmental Studies, Kyoto University and Professor Minoru Suzuki of the Institute for Composite Nuclear Science, Kyoto University.

NEWS

1
2
bottom of page